Posts Tagged ‘Switzerland’
Alithea Genomics closes a CHF 1 million seed round
Alithea Genomics, a Lausanne-based fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of a CHF 1 million seed financing round led by the Novalis Biotech Acceleration fund, with the participation of Swiss-based private investors. Alithea has developed a proprietary technology called Bulk RNA Barcoding and sequencing (BRB-seq), which enables the preparation…
Read MoreSpArk, the centre for movement science and technologies, is born!
This new centre, dedicated to sport and performance, is the result of collaboration between the City of Sion and The Ark Foundation. Officially launched on Thursday 19 May, SpArk aims to exploit the potential of digitalisation in health, sport and performance. The new cluster aims to be a driving force for economic development, by…
Read MoreHemostOD creates ex vivo blood platelets
HemostOD has developed a solution for ex vivo on-demand production of blood platelets. The company just received a CHF 100 000 Tech Seed loan from the Foundation for Technological Innovation (FIT). Worldwide, 10 million platelet concentrates are transfused each year. Platelets are small blood cells whose function is to stop bleeding. Today, patients can only…
Read MorePodcast: Claude Clément
BioAlps President, Claude Clément, discusses career choices and how to lead innovation in the healthcare industry in the podcast What To Do Next? Claude Clément first worked in R&D for the watch industry (Swatch Group🇨🇭), then entered the world of medical technologies by heading the diversification activities of Swatch in the field of wearable programmable drug delivery…
Read MoreA revolutionary home dialysis device made in Switzerland
The VersiTMPD Cycler System conceived and developed by Debiotech and licensed to Fresenius Medical Care receives FDA clearance
Read MoreEUR 1 million Eurostars grant for Limula and Ceidos
The two swiss biotech startups signed an agreement with Stemmatters in Portugal. They received a Eurostars grant of EUR 1.14 million to merge their expertise to develop platforms for the automated production of cell and gene therapy products. Chimeric antigen receptor (CAR) T-cell therapies have shown exceptional clinical efficacy for the treatment of multiple…
Read MorePlair SA raised CHF 2,7 million
A grant to fund the Rapid-C Real-Time Microbial Detector Plair SA, based in Plan-les-Ouates, Geneva, has been awarded CHF 2.7 million in funding from the State Secretariat for Education, Research and Innovation SERI and the EIC Accelerator (former SME Instrument), a highly competitive programme of the European Commission offering funding, coaching and business acceleration services…
Read MoreNeurosoft Bioelectronics raised CHF 3 Million
The Geneva-based company developed soft and flexible electrodes which can seamlessly interface with the brain Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165 000 through the European Research Council…
Read MoreTech4Eva 2022 cohort
13 growth-stage startups and 15 early-stage start-ups and projects have been selected for the 2022 program. Tech4Eva is an EPFL initiative that aims at creating a long-term impact for FemTech startups and a global FemTech Community. The 2022 international cohort, selected from a total of 124 applications, is mainly represented by Swiss-based, USA-based and…
Read MoreDayOne Accelerator 2.0
Three programmes that enable the growth of global healthcare and medtech startups at various stages of their development Digital Health Nation Digital Health Nation is an NTN Innovation Booster powered by Innosuisse that aims at transforming and improving the Swiss healthcare system, but more importantly, patients’ lives. Day One helps the applicants with all the…
Read More